New treatment options for lipid-lowering therapy in subjects with type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New treatment options for lipid-lowering therapy in subjects with type 2 diabetes

Published:2017-12-19 Issue:3 Volume:55 Page:209-218
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Scicali Roberto,Di Pino Antonino,Ferrara Viviana,Urbano Francesca,Piro Salvatore,Rabuazzo Agata Maria,Purrello Francesco

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00592-017-1089-4/fulltext.html

Reference95 articles.

1. Anderson KM (1987) Cholesterol and mortality. JAMA 257:2176. https://doi.org/10.1001/jama.1987.03390160062027

2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, J Am Med Assoc 285:2486–2497. https://doi.org/10.1001/jama.285.19.2486

3. Fredrickson DS (1971) An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med 75:471. https://doi.org/10.7326/0003-4819-75-3-471

4. Tomkin G, Owens D (2017) Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes Targets Ther 10:333–343. https://doi.org/10.2147/DMSO.S115855

5. Haffner SM, Lehto S, Rönnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234. https://doi.org/10.1056/NEJM199807233390404

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low serum dehydroepiandrosterone is associated with diabetic dyslipidemia risk in males with type 2 diabetes;Frontiers in Endocrinology;2023-11-24

2. Advances in Treatment of Dyslipidemia;International Journal of Molecular Sciences;2023-08-27

3. Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice;Journal of Clinical Medicine;2023-03-22

4. Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes;BMC Endocrine Disorders;2023-02-01

5. Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease;International Journal of Cardiology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3